(Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202312 | 202212 | % Var | 202312 | 202212 | % Var | 202303 | 202203 | % Var | |
| Sales | 2.16 | 1.00 | 116.00 | 3.70 | 1.73 | 113.87 | 1.74 | 0.23 | 656.52 |
| Other Income | 0.37 | 0.00 | 0.00 | 0.60 | 4.03 | -85.11 | 4.33 | 0.48 | 802.08 |
| PBIDT | 0.06 | 0.02 | 200.00 | 0.59 | 0.44 | 34.09 | 0.55 | 0.04 | 1275.00 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBDT | 0.06 | 0.02 | 200.00 | 0.59 | 0.44 | 34.09 | 0.55 | 0.04 | 1275.00 |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBT | 0.06 | 0.02 | 200.00 | 0.59 | 0.44 | 34.09 | 0.55 | 0.04 | 1275.00 |
| TAX | 0.02 | 0.01 | 100.00 | 0.16 | 0.13 | 23.08 | 0.14 | 0.01 | 1300.00 |
| Deferred Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PAT | 0.04 | 0.01 | 300.00 | 0.43 | 0.31 | 38.71 | 0.41 | 0.03 | 1266.67 |
| Equity | 48.85 | 48.85 | 0.00 | 48.85 | 48.85 | 0.00 | 48.85 | 48.85 | 0.00 |
| PBIDTM(%) | 2.78 | 2.00 | 38.89 | 15.95 | 25.43 | -37.30 | 31.61 | 17.39 | 81.75 |
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1669.95 |
| Dr. Reddys Lab | 1242.75 |
| Cipla | 1230.00 |
| Zydus Lifesciences | 935.00 |
| Lupin | 2337.95 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: